SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,625,054 | +13.7% | 219,774 | +3.2% | 0.05% | +14.6% |
| Q2 2023 | $41,003,219 | -21.0% | 213,048 | -16.9% | 0.04% | -21.2% |
| Q1 2023 | $51,887,595 | +96.0% | 256,273 | +24.4% | 0.05% | +85.7% |
| Q4 2022 | $26,470,876 | +4.2% | 205,983 | +11.0% | 0.03% | 0.0% |
| Q3 2022 | $25,392,000 | -32.0% | 185,569 | -12.1% | 0.03% | -28.2% |
| Q2 2022 | $37,337,000 | +15.2% | 211,021 | -6.2% | 0.04% | +39.3% |
| Q1 2022 | $32,418,000 | -6.6% | 225,042 | +0.2% | 0.03% | +55.6% |
| Q4 2021 | $34,714,000 | +5.0% | 224,537 | +15.3% | 0.02% | 0.0% |
| Q3 2021 | $33,052,000 | +16.4% | 194,661 | +8.2% | 0.02% | +20.0% |
| Q2 2021 | $28,399,000 | +12.1% | 179,879 | -1.4% | 0.02% | +15.4% |
| Q1 2021 | $25,325,000 | -35.3% | 182,376 | -18.4% | 0.01% | -35.0% |
| Q4 2020 | $39,163,000 | – | 223,608 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |